Evidence map›Paper›PMID 18498181›Full record

ArticleAnalytical chemistry2008

Fluorescence recovery assay for the detection of protein-DNA binding.

Xiaoyang Xu, Zhen Zhao, Lidong Qin, Wei Wei, Jon E Levine, Chad A Mirkin

Abstract read
In one paragraph

Article in Analytical chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyang XuDepartment of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.
Zhen Zhao
Lidong Qin
Wei Wei
Jon E Levine
Chad A Mirkin

Funding

TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancerU54CA119341 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MIRKIN, CHAD A. · 2005 to 2009
$19.9M
Chicago Center for Reproductive ResearchU54HD041859 · NICHD · UNIVERSITY OF CHICAGO · PI RADOVICK, SALLY · 2003 to 2007
$6.6M
NIH Director's Pioneer Award (RMI)DP1OD000285 · OD · NORTHWESTERN UNIVERSITY · PI MIRKIN, CHAD A. · 2004 to 2008
$3.7M
NEUROENDOCRINE REGULATION OF LHRH RELEASER01HD020677 · NICHD · NORTHWESTERN UNIVERSITY · PI LEVINE, JON E · 1985 to 2006
$1.2M
NCI NIH HHS U54 CA119341NICHD NIH HHS R01 HD020677NICHD NIH HHS R01 HD20677NICHD NIH HHS U54 HD041859NIH HHS DP1 OD000285
6 · The paper itself

Abstract

We report a novel and straightforward fluorescence recovery assay which enables the detection of protein-DNA interactions and simultaneously determines relative binding affinities of sequence-specific DNA-binding proteins for a variety of DNA sequences in a multiplexed format. The detection of protein-DNA binding is accomplished by monitoring fluorescence recovery during exonuclease digestion of DNA sequences that are modified with fluorophore-quencher pairs. Retardation of fluorescence recovery occurs with binding of the protein to the putative DNA binding element, which arrests exonuclease digestion. The assay detects protein-DNA binding in a homogeneous solution simply, quickly, and reliably without using radioisotopes. Multiplexing is possible by labeling different DNA sequences with spectrally distinct dyes, allowing simultaneous analysis of experimental and control binding reactions in the same mixture.

Indexed as

DNAEstrogen Receptor alphaFluorescenceLuminescent MeasurementsProtein BindingReceptors, CalcitriolDNAEstrogen Receptor alphaReceptors, Calcitriol

Identifiers

PMID18498181
PMCPMC8192077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.